FTSE All-Share
4 955,99
|
-9,39
|
-0,19 %
|
Analysen zu FTSE All-Share-Werten
08.02.24 | BAT Buy | Jefferies & Company Inc. | |
08.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
08.02.24 | BAT Neutral | JP Morgan Chase & Co. | |
08.02.24 | Unilever Underweight | JP Morgan Chase & Co. | |
08.02.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
08.02.24 | Unilever Sector Perform | RBC Capital Markets | |
07.02.24 | BAT Buy | Jefferies & Company Inc. | |
07.02.24 | BP Buy | UBS AG | |
07.02.24 | BP Underweight | JP Morgan Chase & Co. | |
07.02.24 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
06.02.24 | BP Overweight | Barclays Capital | |
06.02.24 | BP Underweight | JP Morgan Chase & Co. | |
06.02.24 | BP Outperform | RBC Capital Markets | |
06.02.24 | BP Hold | Jefferies & Company Inc. | |
06.02.24 | GSK Buy | UBS AG | |
06.02.24 | Vodafone Group Buy | UBS AG | |
06.02.24 | BP Buy | UBS AG | |
05.02.24 | BAT Buy | Jefferies & Company Inc. | |
05.02.24 | Shell Buy | Jefferies & Company Inc. | |
05.02.24 | BP Outperform | RBC Capital Markets | |
05.02.24 | Vodafone Group Buy | Deutsche Bank AG | |
05.02.24 | GSK Buy | Deutsche Bank AG | |
05.02.24 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
05.02.24 | Vodafone Group Equal Weight | Barclays Capital | |
05.02.24 | National Grid Buy | Jefferies & Company Inc. | |
02.02.24 | Glencore Equal Weight | Barclays Capital | |
02.02.24 | GSK Equal Weight | Barclays Capital | |
02.02.24 | HSBC Holdings Overweight | Barclays Capital | |
02.02.24 | Shell Outperform | RBC Capital Markets | |
01.02.24 | Shell Buy | Jefferies & Company Inc. | |
01.02.24 | Diageo Underperform | RBC Capital Markets | |
01.02.24 | Glencore Buy | Jefferies & Company Inc. | |
01.02.24 | Shell Overweight | Barclays Capital | |
01.02.24 | Unilever Overweight | Barclays Capital | |
01.02.24 | GSK Halten | DZ BANK | |
01.02.24 | Glencore Outperform | RBC Capital Markets | |
01.02.24 | Shell Outperform | RBC Capital Markets | |
01.02.24 | Shell Neutral | UBS AG | |
01.02.24 | GSK Underweight | JP Morgan Chase & Co. | |
01.02.24 | GSK Buy | Deutsche Bank AG |